Protein-fragment complementation assays (PCA) in small GTPase research and drug discovery

被引:6
|
作者
Westwick, John K. [1 ]
Michnick, Stephen W. [1 ]
机构
[1] Univ Montreal, Canada Res, Chair Integrat Genom, Dept Biochim, Montreal, PQ H3C 3J7, Canada
来源
REGULATORS AND EFFECTORS OF SMALL GTPASES: RAS FAMILY | 2006年 / 407卷
关键词
D O I
10.1016/S0076-6879(05)07032-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Small GTPases of the Ras and Rho families are among the most studied signaling proteins and represent promising therapeutic targets for human neoplastic disease. Despite the high level of interest in these proteins, direct analysis of most aspects of Ras protein biology in living cells has not been possible, because much of the details of Ras signaling cannot be studied in vitro but requires simple cell-based assays. Here we describe a strategy for directly analyzing Ras signaling pathways in living cells using protein-fragment complementation assays (PCA) based on fragments of intensely fluorescent proteins. The assays allow for spatial and temporal analysis of protein complexes including those that form upstream and downstream from Ras proteins, as well as complexes of Ras proteins with regulator and effector proteins. We describe high-throughput quantitative microscopic methods to follow temporal changes in complex subcellular location and quantity (high-content assays). Spatial and temporal changes in response to perturbations (chemical, siRNA, hormones) allow for delineation of Ras signaling networks and a general and high-throughput approach to identify drugs that act directly or indirectly on Ras pathways.
引用
收藏
页码:388 / +
页数:17
相关论文
共 50 条
  • [1] Universal strategies in research and drug discovery based on protein-fragment complementation assays
    Michnick, Stephen W.
    Ear, Po Hien
    Manderson, Emily N.
    Remy, Ingrid
    Stefan, Eduard
    NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (07) : 569 - 582
  • [2] Universal strategies in research and drug discovery based on protein-fragment complementation assays
    Stephen W. Michnick
    Po Hien Ear
    Emily N. Manderson
    Ingrid Remy
    Eduard Stefan
    Nature Reviews Drug Discovery, 2007, 6 : 569 - 582
  • [3] Targeting α-synuclein oligomers by protein-fragment complementation for drug discovery in synucleinopathies
    Moussaud, Simon
    Malany, Siobhan
    Mehta, Alka
    Vasile, Stefan
    Smith, Layton H.
    McLean, Pamela J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (05) : 589 - 603
  • [4] Application of protein-fragment complementation assays in cell biology
    Remy, Ingrid
    Michnick, Stephen W.
    BIOTECHNIQUES, 2007, 42 (02) : 137 - +
  • [5] Measuring drug action in the cellular context using protein-fragment complementation assays
    Yu, H
    West, M
    Keon, BH
    Bilter, GK
    Owens, S
    Lamerdin, J
    Westwick, JK
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2003, 1 (06) : 811 - 822
  • [6] Chemical genetic strategies to delineate MAP kinase signaling pathways using protein-fragment complementation assays (PCA)
    Michnick, Stephen W.
    MacDonald, Marnie L.
    Westwick, John K.
    METHODS, 2006, 40 (03) : 287 - 293
  • [7] Clonal selection and in vivo quantitation of protein interactions with protein-fragment complementation assays
    Remy, I
    Michnick, SW
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (10) : 5394 - 5399
  • [8] Three decades of protein-fragment complementation
    Michnick, Stephen W.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2025, 26 (01) : 3 - 4
  • [9] Detection of Polyglutamine Protein Oligomers in Living Cells Using Protein-Fragment Complementation Assays
    Tada, Masayoshi
    Kerppola, Tom K.
    Decker, Stuart J.
    Todi, Sokol V.
    Scaglione, Matthew K.
    Costa, Maria do Carmo P.
    Paulson, Henry
    NEUROLOGY, 2010, 74 (09) : A83 - A83
  • [10] Protein-fragment complementation assays for large-scale analysis of protein-protein interactions
    Blaszczak, Ewa
    Lazarewicz, Natalia
    Sudevan, Aswani
    Wysocki, Robert
    Rabut, Gwenael
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2021, 49 (03) : 1337 - 1348